BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 234 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $212 | +0.5% | 30 | 0.0% | 0.00% | – |
| Q2 2023 | $211 | -99.4% | 30 | -99.3% | 0.00% | – |
| Q1 2023 | $34,257 | +35584.4% | 4,108 | -50.7% | 0.00% | – |
| Q4 2022 | $96 | -99.9% | 8,325 | -27.6% | 0.00% | -100.0% |
| Q1 2022 | $187,000 | +6.9% | 11,495 | -8.9% | 0.00% | 0.0% |
| Q4 2021 | $175,000 | -14.6% | 12,618 | -11.5% | 0.00% | -40.0% |
| Q3 2021 | $205,000 | +5.7% | 14,255 | +16.0% | 0.01% | 0.0% |
| Q2 2021 | $194,000 | +54.0% | 12,291 | -0.9% | 0.01% | +25.0% |
| Q1 2021 | $126,000 | +53.7% | 12,406 | -48.3% | 0.00% | +33.3% |
| Q3 2020 | $82,000 | – | 24,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 1,105,673 | $8,237,000 | 6.28% |
| Sarissa Capital Management LP | 8,175,000 | $60,903,000 | 6.22% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,980,870 | $22,207,000 | 2.78% |
| DG Capital Management, LLC | 1,075,732 | $8,014,000 | 1.70% |
| Ghost Tree Capital, LLC | 900,000 | $6,705,000 | 1.49% |
| Parkman Healthcare Partners LLC | 538,370 | $4,011,000 | 1.03% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,835,810 | $43,477,000 | 0.86% |
| Formidable Asset Management, LLC | 470,419 | $3,470,000 | 0.80% |
| KNOTT DAVID M | 219,461 | $1,635,000 | 0.74% |
| Altium Capital Management LP | 250,000 | $1,863,000 | 0.70% |